FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442103019 2 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Some
    2 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely nitrofural 2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely esterified estrogen 625 microgram and methyltestosterone 1.25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Nicotine (as nicotine polacrilex) 2 mg oral gum chewing gum Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely paracetamol 24 milligram/1 milliliter and promethazine hydrochloride 300 microgram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Mucin 63 mg and xylitol 39 mg oromucosal lozenge Count of base of active ingredient False 2 Inferred relationship Some
    Theophylline 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation Count of base of active ingredient False 2 Inferred relationship Some
    Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Frangula 80 microgram/mg and Sterculia gum 620 microgram/mg oral granules Count of base of active ingredient False 2 Inferred relationship Some
    Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely cefepime (as cefepime hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely calcium carbonate 1.5 gram and colecalciferol 10 microgram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Ampicillin (as ampicillin sodium) 1 g and sulbactam (as sulbactam sodium) 500 mg powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Estrone 2 mg/mL suspension for injection Has concentration strength numerator value False 2 Inferred relationship Some 1
    Nafcillin (as nafcillin sodium) 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely ampicillin (as ampicillin sodium) 2 gram and sulbactam (as sulbactam sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Aspirin 500 mg and glycine 133 mg orodispersible tablet Count of base of active ingredient False 2 Inferred relationship Some
    Alprazolam 2 mg orodispersible tablet Has presentation strength numerator value False 2 Inferred relationship Some 1
    Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely oxacillin (as oxacillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet Count of base of active ingredient False 2 Inferred relationship Some
    Calcium electrolyte 1.25 g and colecalciferol 10 microgram chewable tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Diazepam 2 mg/mL rectal solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely omeprazole 20 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Bromazine hydrochloride 2.5 mg/mL and codeine phosphate 2 mg/mL oral solution Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution Count of base of active ingredient False 2 Inferred relationship Some
    Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely methylprednisolone 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False 2 Inferred relationship Some
    Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection Count of base of active ingredient False 2 Inferred relationship Some
    Acetic acid 9 mg/g and oxyquinoline (as oxyquinoline sulfate) 250 microgram/g vaginal gel Count of base of active ingredient False 2 Inferred relationship Some
    Calcium carbonate 6.25 mg/mL and colecalciferol 2.2 unit/mL oral solution Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False 2 Inferred relationship Some
    Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution Count of base of active ingredient False 2 Inferred relationship Some
    Thioridazine 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Codeine phosphate 2 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely fluorescein sodium stain 2.5 milligram/1 milliliter and proxymetacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution Count of base of active ingredient False 2 Inferred relationship Some
    Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet Has presentation strength numerator value False 2 Inferred relationship Some 2
    Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL ear solution Count of base of active ingredient False 2 Inferred relationship Some
    Memantine hydrochloride 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution Count of base of active ingredient False 2 Inferred relationship Some
    Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Miconazole nitrate 2.5 mg/g and zinc oxide 150 mg/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Lidocaine hydrochloride 2 mg/mL solution for injection Has concentration strength numerator value False 2 Inferred relationship Some 1
    Clonazepam 2 mg orodispersible tablet Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely gemcitabine (as gemcitabine hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection Count of base of active ingredient False 2 Inferred relationship Some
    Glucose 50 mg/mL and sodium chloride 1.8 mg/mL solution for injection Count of base of active ingredient False 2 Inferred relationship Some
    Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocodone bitartrate 500 microgram/mL and paracetamol 21.7 mg/mL oral solution Count of base of active ingredient False 2 Inferred relationship Some
    Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydrocodone bitartrate 333 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some

    Start Previous Page 21 of 24 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start